This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
PROfound
VISION Trial
mHSPC
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
CONDOR Trial
OSPREY Trial
Bladder Cancer
Bladder Cancer Detection
ADSTILADRIN
Trials in Progress
Trials in Progress
Bladder Cancer
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
ECLIPSE
ESCAPE
FORT
NRG-GU 0101
Masofaniten (EPI-7386)
METANOVA
RTIRE
SHORTER
Right Side
PCCTC
DORA
IRONMAN
PROMISE
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Petros Grivas, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Sumanta (Monty) Kumar Pal, MD
Jaime Landman, MD
Prostate Cancer
Advanced Prostate Cancer
Alicia Morgans, MD, MPH
CRPC with Bone Metastases
Rana R. McKay, MD
Imaging Center
Phillip Koo, MD
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
mHSPC
Alicia Morgans, MD, MPH
nmCRPC
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular, Penile, and Rare GU Malignancies
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
SESAUA 2024
Southern CA GU Cancer Research Forum 2024
AUA Urology Advocacy Summit 2024
ASCO GU 2024
2024 UCSF-UCLA PSMA Conference
SUO 2023
All Conferences
View All
PCF
UroToday Home
Conference Highlights
EAU 2018
EAU 2018
Prostate Cancer
Bladder Cancer
Kidney Cancer
Testis and Penile Cancer
Endourology
Press
EAU 2018 Prostate Cancer
Viewing 36-55 of 87 articles
EAU 2018: Prostate Cancer: Immediate and Late Complications - Laparoscopic
EAU 2018: Prostate Cancer: Immediate and Late Complications - Robotic
EAU 2018: Prostate Cancer: Immediate and Late Complications - Open
EAU 2018: Is Focal Therapy for Prostate Cancer an Attractive Option?
EAU 2018: Impact of Blood Loss During Radical Prostatectomy on the Functional Outcome
EAU 2018: Prevalence and Pathological Characteristics of Anterior Prostate Cancer in a Cohort Of Radical Prostatectomy Patients Diagnosed by Biopsies and MRI
EAU 2018: How Can We Expand Active Surveillance Criteria in Patients with Low- and Intermediate Risk Prostate Cancer without Increasing the Risk of Misclassification: Development of a Novel Risk Calculator
EAU 2018: mCRPC New Drugs and Sequencing
EAU 2018: Prostate MRI Combined with PSA-Density May Reduce the Number of Follow-Up Targeted Biopsies in Men on Active Surveillance for Low-Risk Prostate Cancer
EAU 2018: Prostate-Specific Antigen Response in Men with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide: Results from PROSPER
EAU 2018: Using Clues from Studies of Genomic Evolution to Develop Clinically Applicable Biomarkers
EAU 2018: Local Control is Needed
EAU 2018: Systemic Therapy is the Standard of Care
EAU 2018: Clinical Data and Imaging are Doing the Job
EAU 2018: Clinical Data and Imaging are Doing the Job
EAU 2018: Genomic Screening Should Be Done
EAU 2018: Local and Metastasis Imaging Targeted Treatments are Needed
EAU 2018: Socioeconomic Status and Diagnosis, Treatment, and Mortality in Men with Prostate Cancer: A Nationwide Population-Based Study
EAU 2018: Development of PSA Screening Nomograms for 15-Year Prediction of Prostate Cancer Diagnosis, Mortality, and All-Cause Mortality
EAU 2018: The German Risk-Adapted Prostate Cancer Screening Trial (PROBASE): First Results After Recruitment of 30,000 Men
1
2
3
4
5
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free